alexa Safety And Efficacy Of Ab-interno Canaloplasty (ABiC) For The Treatment Of Open-angle Glaucoma | 61204
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

10th International Conference on Clinical & Experimental Ophthalmology
November 21-23, 2016 Dubai, UAE

Mahmoud Khaimi
Dean McGee Eye Institute, USA
University of Oklahoma, USA
Posters & Accepted Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.C1.049
Abstract
Purpose: To investigate the safety and efficacy of ABiC in reducing IOP and glaucoma medication dependence in OAG. Setting: Dean McGee Eye Institute, United States of America. Methods: This non-randomized, single center study explored the effect of ABiC or combined cataract surgery-ABiC in adult OAG patients. The primary endpoints included mean IOP and mean number of glaucoma medications over a 12-month period. Secondary endpoints included surgical/postsurgical complications and secondary interventions. Results: The study cohort included106subjectswith a baseline mean IOP of 19.5±6.6 mmHg which reduced to15.7±4.4 mm Hg (n=69), 15.0±3.8 mm Hg (n=69) and 13.9±1.9 mm Hg (n=20) at 3, 6 and 12 months postoperative, respectively. Medication dependency reduced from 2±1 drops before surgery to 0±1 drops at 3, 6 and 12 months postoperative, representing a total average decrease of 28.7% in IOP and 100% in glaucoma medications at 12 months postoperative versus baseline. In the group of patients who underwent standalone ABiC, mean IOP was reduced by 36.8% from 22.0±8.2 mm Hg preoperatively (n=38) to 13.9±1.6 mm Hg at 12 months postoperative (n=8) with a 50% reduction in medication. There were no intra-or postoperative complications. Conclusion: ABiC is safe and effective in achieving IOP reduction and reduces dependence on anti-glaucoma medications in patients with OAG, both as a standalone procedure and combined with phacoemulsification.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version